Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids
Jitske Jansen, Katharina C. Reimer, James S. Nagai, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 217-231.e8
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Human organoids in basic research and clinical applications
Xiaoyan Tang, Shanshan Wu, Da Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 240
Human disease models in drug development
Anna Loewa, James J. Feng, Sarah Hedtrich
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 8, pp. 545-559
Open Access | Times Cited: 139
Organoids: The current status and biomedical applications
Siqi Yang, Hai‐Jie Hu, Heng‐Chung Kung, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 104
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 98
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
Melissa L. Boby, D. Fearon, Matteo P. Ferla, et al.
Science (2023) Vol. 382, Iss. 6671
Open Access | Times Cited: 92
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Feng Ren, Alex Aliper, Jian Chen, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 79
The role of oxidative stress in the pathogenesis of infections with coronaviruses
Chandrima Gain, Sihyeong Song, Tyler Angtuaco, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 65
Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation
J. Jeya Vandana, Cassandra Manrique, Lauretta A. Lacko, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 571-591
Open Access | Times Cited: 63
Long-term interplay between COVID-19 and chronic kidney disease
Helmut Schiffl, Susanne Lang
International Urology and Nephrology (2023) Vol. 55, Iss. 8, pp. 1977-1984
Open Access | Times Cited: 49
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Elena Garreta, Patricia Prado, Megan L. Stanifer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 857-873.e9
Open Access | Times Cited: 67
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 8, pp. 485-498
Open Access | Times Cited: 66
Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury
Christian Hinze, Christine Kocks, Janna Leiz, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 56
MSCs vs. iPSCs: Potential in therapeutic applications
Kalaiselvaan Thanaskody, Amirah Syamimi Jusop, Gee Jun Tye, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 54
Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids
Jessica M. Vanslambrouck, Sean B. Wilson, Ker Sin Tan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 601-619
Open Access | Times Cited: 43
Roadmap for focused ion beam technologies
Katja Höflich, G. Hobler, Frances I. Allen, et al.
Applied Physics Reviews (2023) Vol. 10, Iss. 4
Open Access | Times Cited: 37
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Zhouyi Rong, Hongcheng Mai, Saketh Kapoor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 25
Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids
Fjodor A. Yousef Yengej, Jitske Jansen, Carola M. E. Ammerlaan, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 6
Open Access | Times Cited: 24
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 14
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19
Zhouyi Rong, Hongcheng Mai, Gregor Ebert, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 12, pp. 2112-2130.e10
Open Access | Times Cited: 10
Kidney immunology from pathophysiology to clinical translation
Christian Kurts, Sibylle von Vietinghoff, Christian F. Krebs, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 1
Human kidney organoids for modeling the development of different diseases
Elena Ceccotti, Armina Semnani, Benedetta Bussolati, et al.
Current topics in developmental biology/Current Topics in Developmental Biology (2025)
Closed Access | Times Cited: 1
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors
Melissa L. Boby, D. Fearon, Matteo P. Ferla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 53
JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids
Sarah Nystrom, Guojie Li, Somenath Datta, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top